2021-01-02,b'@MDollares @Benjami80128868 $OMER Narsoplimab is better than $CALTX $CALT Nefecon. IgAN patients and now in phase 3. Primary Completion Aug 2020 https://t.co/7dyUF9r4YC Reduced proteinuria (phase 2) in IgA nephropathy patients by 50%-90%. https://t.co/EShx0wYm1C'
2021-01-02,"b'@Benjami80128868 @MDollares Novartis iptacopan has so far better results than $CALTX $CALT Nefecon. ""significantly reduced proteinuria \xe2\x80\x93 a marker of inflammation in the kidneys \xe2\x80\x93 by 49%"" https://t.co/5yVHmE0dln'"
2020-12-30,b'RT @Alexisoomoz: Stocks to watch Dec. 30 thru Dec. 31 $tgs $omi $regi $eurn $jwn $cde $skt $cxw $cgc $fro $pen $Loma $acy $uuu $pacb $sig $\xe2\x80\xa6'
2020-12-30,b'Stocks to watch Dec. 30 thru Dec. 31 $tgs $omi $regi $eurn $jwn $cde $skt $cxw $cgc $fro $pen $Loma $acy $uuu $pacb $sig $fvrr $repL $cLne $nvta $caLt &amp; $BIOL BIOLASE INC. https://t.co/mh9yMraMLE stock tip $BIOL https://t.co/WmPq1IqeHI'
2021-01-07,b'50 DMA Support today: $PVG $JHS $CALT ... https://t.co/aW7zteKP9U'
2021-01-06,b'50 DMA Support today: $AFINP $CALT $SREA ... https://t.co/aW7zteKP9U'
